Back to search
FDAFDA · Food and drugs·Recall number D-1076-2017

Adenosine in 0.9% Sodium Chloride 30mL, 90 mg/30 mL (3 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222; NDC 52533-236-03

Published August 16, 2017 · Recall initiated: July 14, 2017

Summary

FDA records drug Class II recall D-1076-2017, published August 16, 2017 and initiated July 14, 2017. Recalling firm: Cantrell Drug Company; Status: Terminated; Reported quantity: 6210 syringes; Lot: Lot #: 9814, 9831 BUD: 9/12/2017; 10059, BUD: 10/18/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Sterility Assurance.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cantrell Drug Company
Distributor
Nationwide within the US
Lot
Lot #: 9814, 9831 BUD: 9/12/2017; 10059, BUD: 10/18/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Adenosine in 0.9% Sodium Chloride 30mL, 90 mg/30 mL (3 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222; NDC 52533-236-03 recalled?

Yes. FDA published recall D-1076-2017 on August 16, 2017. Reported hazard: Lack of Sterility Assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter